Sesen Bio's stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment

Business

MarketWatch 13 August, 2021 - 02:33pm 26 views

Will sesen bio get FDA approval?

Aug 13 (Reuters) - The U.S. Food and Drug Administration has declined to approve Sesen Bio Inc's lead therapy candidate for a type of bladder cancer, the drug developer said on Friday. reuters.comU.S. FDA declines to approve Sesen Bio's bladder cancer treatment

Business Stories